Anti-TNF-alpha therapeutics in chronic inflammatory diseases – seeing in the dark
Multiple diseases are covered by the umbrella of poorly understood etiology coupled to an exaggerated or misguided inflammatory response. At first… Read more »
Multiple diseases are covered by the umbrella of poorly understood etiology coupled to an exaggerated or misguided inflammatory response. At first… Read more »
June is Cancer Immunotherapy Awareness Month, an initiative to increase the public’s awareness of the revolutionary new treatment approach.… Read more »
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with heterogeneity in clinical manifestations and disease… Read more »
In September 2009, Journal of Translational Medicine (JTM) and the then International Society for the Biological Therapy of Cancer… Read more »
The Human Leukocyte Antigen (HLA) is the most polymorphic region of the genome, with a key role in the immunological response. In… Read more »